R. Teng

463 total citations
7 papers, 412 citations indexed

About

R. Teng is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, R. Teng has authored 7 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in R. Teng's work include Diabetes Treatment and Management (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Pharmacology and Obesity Treatment (3 papers). R. Teng is often cited by papers focused on Diabetes Treatment and Management (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Pharmacology and Obesity Treatment (3 papers). R. Teng collaborates with scholars based in United States, South Korea and France. R. Teng's co-authors include Keith D. Kaufman, Debora Williams‐Herman, John M. Amatruda, Gregory T. Golm, B. J. Goldstein, J. Johnson, Michael J. Davies, Jeremy Johnson, Barry J. Goldstein and H. Steinberg and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Obesity and Metabolism and Current Medical Research and Opinion.

In The Last Decade

R. Teng

7 papers receiving 395 citations

Peers

R. Teng

EDM

MB

SURGE

PHARM

ONCOL

Sandra Thiemann Germany

Jennifer Newman United States

Carol Wilson United States

Didier Saur France

Masashi Hirayama Japan

Elizabeth Bandeira-Echtler Germany

Zbyněk Schroner Slovakia

Renee Kaste Germany

Shoba Ravichandran United States

Chiaki Kuriyama Japan

Sandra Thiemann Germany

R. Teng

396 ×1.0

EDM

146 ×0.8

MB

137 ×0.9

SURGE

50 ×0.6

PHARM

99 ×1.3

ONCOL

Citations per year, relative to R. Teng R. Teng (= 1×) peers Sandra Thiemann

Countries citing papers authored by R. Teng

Since Specialization

Citations

This map shows the geographic impact of R. Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Teng more than expected).

Fields of papers citing papers by R. Teng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Teng. The network helps show where R. Teng may publish in the future.

Co-authorship network of co-authors of R. Teng

This figure shows the co-authorship network connecting the top 25 collaborators of R. Teng. A scholar is included among the top collaborators of R. Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Teng. R. Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Bays, Harold, Seth J. Baum, Eliot A. Brinton, et al.. (2021). Effect of bempedoic acid plus ezetimibe fixed-dose combination vs ezetimibe or placebo on low-density lipoprotein cholesterol in patients with type 2 diabetes and hypercholesterolemia not treated with statins. SHILAP Revista de lepidopterología. 8. 100278–100278. 12 indexed citations

2.

Henry, Robert R., Bart Staels, Vivian Fonseca, et al.. (2013). Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone—a factorial study. Diabetes Obesity and Metabolism. 16(3). 223–230. 34 indexed citations

3.

Yoon, Kun‐Ho, H. Steinberg, R. Teng, et al.. (2012). Efficacy and safety of initial combination therapy with sitagliptin and pioglitazone in patients with type 2 diabetes: a 54‐week study. Diabetes Obesity and Metabolism. 14(8). 745–752. 29 indexed citations

4.

Yoon, Kun‐Ho, R. Teng, Gregory T. Golm, et al.. (2011). Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of β-cell function in patients with type 2 diabetes. International Journal of Clinical Practice. 65(2). 154–164. 47 indexed citations

5.

Williams‐Herman, Debora, Lei Xu, R. Teng, et al.. (2011). Effect of initial combination therapy with sitagliptin and metformin on β ‐cell function in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 14(1). 67–76. 37 indexed citations

6.

Williams‐Herman, Debora, J. Johnson, R. Teng, et al.. (2010). Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 12(5). 442–451. 135 indexed citations

7.

Williams‐Herman, Debora, Jeremy Johnson, R. Teng, et al.. (2009). Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study. Current Medical Research and Opinion. 25(3). 569–583. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact